Cost of Surgical Treatment of Obesity and Its Impact on Healthcare Expense-Nationwide Data from a Polish Registry.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
08 01 2023
Historique:
received: 28 11 2022
revised: 03 01 2023
accepted: 05 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Weight loss surgery is linked to health benefits and may reduce the cost to the public healthcare systems. The aim of this study was to assess the cost and cost-structure in the one-year periods before and after a bariatric surgery in the Polish nationwide registry. The study included 2390 obese adults which underwent surgical treatment for obesity in 2017. The cost structure and the total costs per patient for one year before bariatric surgery, preoperatively, and for one year after surgery were analyzed. The total cost of the postoperative period was about PLN 3 million lower than during the preoperative period. After bariatric surgery, a reduction of approximately 59% in costs associated with hospital treatment was observed. The costs of outpatient specialist services, hospital treatment, psychiatric care, and addiction treatment also significantly decreased. There was a negative correlation between the changes in the cost of treatment of patients undergoing obesity surgery and their age. The health care cost during the period of one year after bariatric surgery is lower than in the year preceding the surgery (a greater cost difference is observed in younger people). This is mainly influenced by the reduction in costs associated with hospital treatment.

Identifiants

pubmed: 36673873
pii: ijerph20021118
doi: 10.3390/ijerph20021118
pmc: PMC9859611
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356
pubmed: 36280539
SAGE Open Med. 2014 Apr 23;2:2050312114530917
pubmed: 26770722
Surg Today. 2021 Jan;51(1):61-69
pubmed: 32725350
Cad Saude Publica. 2015 Aug;31(8):1587-601
pubmed: 26375639
BMJ. 2013 Oct 22;347:f5934
pubmed: 24149519
Eat Weight Disord. 2022 May;27(4):1457-1466
pubmed: 34426952
Medicine (Baltimore). 2019 Jan;98(3):e13824
pubmed: 30653091
Obesity (Silver Spring). 2011 Mar;19(3):581-7
pubmed: 20829800
J Glob Health Rep. 2019;3:
pubmed: 34027129
Obes Surg. 2022 Apr;32(4):998-1004
pubmed: 35083702
Value Health. 2017 Jan;20(1):85-92
pubmed: 28212974
Am Heart J. 2011 Oct;162(4):717-24
pubmed: 21982665
Obes Surg. 2018 Feb;28(2):338-348
pubmed: 28735376
Obes Surg. 2012 Feb;22(2):266-70
pubmed: 22139831
Obes Surg. 2021 Nov;31(11):4754-4760
pubmed: 34345959
Health Aff (Millwood). 2004 Mar-Apr;23(2):199-205
pubmed: 15046144
J Manag Care Spec Pharm. 2021 Mar;27(3):354-366
pubmed: 33470881
JAMA. 2003 Jan 8;289(2):187-93
pubmed: 12517229
Obes Surg. 2017 Aug;27(8):2179-2192
pubmed: 28550438
JAMA. 2013 Aug 21;310(7):742-3
pubmed: 23989885
Obes Rev. 2020 Jan;21(1):e12932
pubmed: 31733033
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
BMC Health Serv Res. 2022 Jan 7;22(1):41
pubmed: 34996426
J Am Geriatr Soc. 2017 Feb;65(2):257-268
pubmed: 27641543
Sao Paulo Med J. 2011;129(5):291-9
pubmed: 22069127
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897

Auteurs

Magdalena Osińska (M)

Department of Internal Diseases, Endocrinology and Diabetology, National Medical Institute of the Ministry of the Interior and Administration, 137 Wołoska Str., 02-507 Warsaw, Poland.

Iwona Towpik (I)

Department of Internal Diseases, Diabetology, and Endocrinology, Collegium Medicum, University of Zielona Góra, 28 Zyty Str., 65-046 Zielona Góra, Poland.

Yaroslav Sanchak (Y)

Department of Internal Diseases, Endocrinology and Diabetology, National Medical Institute of the Ministry of the Interior and Administration, 137 Wołoska Str., 02-507 Warsaw, Poland.

Edward Franek (E)

Department of Internal Diseases, Endocrinology and Diabetology, National Medical Institute of the Ministry of the Interior and Administration, 137 Wołoska Str., 02-507 Warsaw, Poland.
Department of Human Epigenetics, Mossakowski Medical Research Institute, 5 Pawińskiego Str., 02-106 Warsaw, Poland.

Andrzej Śliwczyński (A)

Faculty of Medicine, Lazarski University, 43 Świeradowska Str., 02-662 Warsaw, Poland.

Magdalena Walicka (M)

Department of Internal Diseases, Endocrinology and Diabetology, National Medical Institute of the Ministry of the Interior and Administration, 137 Wołoska Str., 02-507 Warsaw, Poland.
Department of Human Epigenetics, Mossakowski Medical Research Institute, 5 Pawińskiego Str., 02-106 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH